Back to Journals » Neuropsychiatric Disease and Treatment
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
1176-6328 (Print) - went to online only in 2009
An international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (4218)
- Volume 20, 2024 (112)
- Volume 19, 2023 (249)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Latest articles:
- 5 records -
Benefits of Combining Antiepileptic Drugs with Vitamin B12 on Redox Balance: Penicillin-Induced Experimental Epilepsy Model
Taskin S, Ozsoy S, Cakir Z
Neuropsychiatric Disease and Treatment 2024, 20:1271-1277
Published Date: 12 June 2024
Multisensory Fusion Training and 7, 8-Dihydroxyflavone Improve Amyloid-β-Induced Cognitive Impairment, Anxiety, and Depression-Like Behavior in Mice Through Multiple Mechanisms
Guo J, Cao Y, Zhang T, Xu C, Liu Z, Li W, Wang Q
Neuropsychiatric Disease and Treatment 2024, 20:1247-1270
Published Date: 12 June 2024
Recent Research Progress on the Use of Transcranial Magnetic Stimulation in the Treatment of Vascular Cognitive Impairment
Li S, Xiao Z
Neuropsychiatric Disease and Treatment 2024, 20:1235-1246
Published Date: 11 June 2024
Development and Validation of Paradigms Based on the Global-First Topological Approach for Alzheimer’s Disease Severity Staging
Bian Z, Wang B, Wu X, Wang K, Jiang Y
Neuropsychiatric Disease and Treatment 2024, 20:1225-1234
Published Date: 10 June 2024
Effectiveness of Vortioxetine in Working Patients with Major Depressive Disorder in China: A Subgroup Analysis of the RELIEVE China Study
Wang G, Si T, Rieckmann A, Ma J, Christensen MC
Neuropsychiatric Disease and Treatment 2024, 20:1211-1223
Published Date: 7 June 2024